Gene therapy of cancer based on interleukin 12

Current Gene Therapy

Volumn 5, Issue 6, 2005, Pages 573-581

  Sangro, Bruno ^a   Melero, Ignacio ^a   Qian, Cheng ^a   Prieto, Jesus ^a  

^a UNIVERSITY CLINIC OF NAVARRA   (Spain)

Author keywords

Biological therapy; Dendritic cells; Gene therapy; Gene transfer techniques; Genetic engineering; Hepatocellular carcinoma; Immunotherapy; Interleukin 12; Liver neoplasms

Indexed keywords

ADENOVIRUS VECTOR; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; LIVER ENZYME; RECOMBINANT INTERLEUKIN 12; TUMOR VACCINE;

ANTINEOPLASTIC ACTIVITY; CANCER IMMUNOTHERAPY; CELL BASED GENE THERAPY; CLINICAL TRIAL; CYTOKINE PRODUCTION; DENDRITIC CELL; DRUG MECHANISM; FATIGUE; FEVER; GENE EXPRESSION; GENE THERAPY; GENE VECTOR; GENETIC TRANSDUCTION; HUMAN; IMMUNOSTIMULATION; INJECTION PAIN; LEUKOPENIA; LIVER DYSFUNCTION; LYMPHOCYTOPENIA; MALAISE; MALIGNANT NEOPLASTIC DISEASE; NAUSEA; NONHUMAN; REVIEW; SIDE EFFECT; SWEATING; TRANSGENE;

ANIMALS; CLINICAL TRIALS; DRUG EVALUATION, PRECLINICAL; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HUMANS; IMMUNOTHERAPY; INTERLEUKIN-12; MODELS, ANIMAL; MODELS, BIOLOGICAL; NEOPLASMS;

ADENOVIRIDAE; ANIMALIA;

EID: 29344476193     PISSN: 15665232     EISSN: None     Source Type: Journal    
DOI: 10.2174/156652305774964712     Document Type: Review

References (71)

1. Alatrash, G., Hutson, T. E., Molto, L., Richmond, A., Nemec, C., Mekhail, T., Elson, P., et al. (2004) Clinical and immunologic effects of subcutaneously administered interleukin-12 and interferon alfa-2b: phase I trial of patients with metastatic renal cell carcinoma or malignant melanoma. J. Clin. Oncol. 22: 2891-900.
2. Andrews, K. J., Ribas, A., Butterfield, L. H., Vollmer, C. M., Eilber, F. C., Dissette, V. B., Nelson, S. D., et al. (2000) Adenovirus-interleukin-12-mediated tumor regression in a murine hepatocellular carcinoma model is not dependent on CD1-restricted natural killer T cells. Cancer Res. 60: 6457-64.
3. Asselin-Paturel, C., Lassau, N., Guinebretiere, J. M., Zhang, J., Gay, F., Bex, F., Hallez, S., et al. (1999) Transfer of the murine interleukin-12 gene in. vivo by a Semliki Forest virus vector induces B16 tumor regression through inhibition of tumor blood vessel formation monitored by Doppler ultrasonography. Gene Ther. 6: 606-15.
4. Barajas, M., Mazzolini, G., Genove, G., Bilbao, R., Narvaiza, I., Schmitz, V., Sangro, B., et al. (2001) Gene therapy of orthotopic hepatocellular carcinoma in rats using adenovirus coding for interleukin 12. Hepatology 33: 52-61.
5. Bennett, J. J., Malhotra, S., Wong, R. J., Delman, K., Zager, J., St-Louis, M., Johnson, P., et al. (2001) Interleukin 12 secretion enhances antitumor efficacy of oncolytic herpes simplex viral therapy for colorectal cancer. Ann. Surg. 233: 819-26.
6. Boggio, K., Di Carlo, E., Rovero, S., Cavallo, F., Quaglino, E., Lollini, P. L., Nanni, P., et al. (2000) Ability of systemic interleukin-12 to hamper progressive stages of mammary carcinogenesis in HER2/neu transgenic mice. Cancer Res. 60: 359-64.
7. Bramson, J., Hitt, M., Gallichan, W. S., Rosenthal, K. L., Gauldie, J. and Graham, F. L. (1996) Construction of a double recombinant adenovirus vector expressing a heterodimeric cytokine: in vitro and in vivo production of biologically active interleukin-12. Hum. Gene Ther. 7: 333-42.
8. Bramson, J. L., Hitt, M., Addison, C. L., Muller, W. J., Gauldie, J. and Graham, F. L. (1996) Direct intratumoral injection of an adenovirus expressing interleukin-12 induces regression and long-lasting immunity that is associated with highly localized expression of interleukin-12. Hum. Gene Ther. 7: 1995-2002.
9. Caruso, M., Pham-Nguyen, K., Kwong, Y. L., Xu, B., Kosai, K. I., Finegold, M., Woo, S. L., et al. (1996) Adenovirus-mediated interleukin-12 gene therapy for metastatic colon carcinoma. Proc. Natl. Acad. Sci. USA 93: 11302-6.
10. Colombo, M. P. and Trinchieri, G. (2002) Interleukin-12 in anti-tumor immunity and immunotherapy. Cytokine Growth Factor Rev. 13: 155-68.
11. Colombo, M. P., Vagliani, M., Spreafico, F., Parenza, M., Chiodoni, C., Melani, C. and Stoppacciaro, A. (1996) Amount of interleukin 12 available at the tumor site is critical for tumor regression. Cancer Res. 56: 2531-4.
12. De Giovanni, C., Nicoletti, G., Landuzzi, L., Astolfi, A., Croci, S., Comes, A., Ferrini, S., et al. (2004) Immunoprevention of HER-2/neu transgenic mammary carcinoma through an interleukin 12-engineered allogeneic cell vaccine. Cancer Res. 64: 4001-9.
13. Divino, C. M., Chen, S. H., Yang, W., Thung, S., Brower, S. T. and Woo, S. L. (2000) Anti-tumor immunity induced by interleukin-12 gene therapy in a metastatic model of breast cancer is mediated by natural killer cells. Breast Cancer Res. Treat. 60: 129-34.
14. Drozdzik, M., Qian, C., Xie, X., Peng, D., Bilbao, R., Mazzolini, G. and Prieto, J. (2000) Combined gene therapy with suicide gene and interleukin-12 is more efficient than therapy with one gene alone in a murine model of hepatocellular carcinoma. J. Hepatol. 32: 279-86.
15. Egilmez, N. K., Jong, Y. S., Sabel, M. S., Jacob, J. S., Mathiowitz, E. and Bankert, R. B. (2000) In situ tumor vaccination with interleukin-12-encapsulated biodegradable microspheres: induction of tumor regression and potent antitumor immunity. Cancer Res. 60: 3832-7.
16. Feijoo, E., Alfaro, C., Mazzolini, G., Serra, P., Penuelas, I., Arina, A., Huarte, E., et al. (2005) Dendritic cells delivered inside human carcinomas are sequestered by interleukin-8. Int. J. Cancer.
17. Furumoto, K., Arii, S., Yamasaki, S., Mizumoto, M., Mori, A., Inoue, N., Isobe, N., et al. (2000) Spleen-derived dendritic cells engineered to enhance interleukin-12 production elicit therapeutic antitumor immune responses. Int. J. Cancer 87: 665-72.
18. Gambotto, A., Tuting, T., McVey, D. L., Kovesdi, I., Tahara, H., Lotze, M. T. and Robbins, P. D. (1999) Induction of antitumor immunity by direct intratumoral injection of a recombinant adenovirus vector expressing interleukin-12. Cancer Gene Ther. 6: 45-53.
19. Ha, S. J., Lee, S. B., Kim, C. M., Shin, H. S. and Sung, Y. C. (1998) Rapid recruitment of macrophages in interleukin-12-mediated tumour regression. Immunology 95: 156-63.
20. Hafner, M., Falk, W., Echtenacher, B. and Mannel, D. N. (1999) Interleukin-12 activates NK cells for IFN-gamma-dependent and NKT cells for IFN-gamma-independent antimetastatic activity. Eur. Cytokine Netw. 10: 541-8.
21. Heinzerling, L. M., Feige, K., Rieder, S., Akens, M. K., Dummer, R., Stranzinger, G. and Moelling, K. (2001) Tumor regression induced by intratumoral injection of DNA coding for human interleukin 12 into melanoma metastases in gray horses. J. Mol. Med. 78: 692-702.
22. Hirschowitz, E. A., Naama, H. A., Evoy, D., Lieberman, M. D., Daly, J. and Crystal, R. G. (1999) Regional treatment of hepatic micrometastasis by adenovirus vector-mediated delivery of interleukin-2 and interleukin-12 cDNAs to the hepatic parenchyma. Cancer Gene Ther. 6: 491-8.
23. Hull, G. W., McCurdy, M. A., Nasu, Y., Bangma, C. H., Yang, G., Shimura, S., Lee, H. M., et al. (2000) Prostate cancer gene therapy: comparison of adenovirus-mediated expression of interleukin 12 with interleukin 12 plus B7-1 for in situ gene therapy and gene-modified, cell-based vaccines. Clin. Cancer Res. 6: 4101-9.
24. Itokawa, Y., Mazda, O., Ueda, Y., Kishida, T., Asada, H., Cui, F. D., Fuji, N., et al. (2004) Interleukin-12 genetic administration suppressed metastatic liver tumor unsusceptible to CTL. Biochem. Biophys. Res. Commun. 314: 1072-9.
25. Jarnagin, W. R., Delman, K., Kooby, D., Mastorides, S., Zager, J., Brennan, M. F., Blumgart, L. H., et al. (2000) Neoadjuvant interleukin-12 immunogene therapy protects against cancer recurrence after liver resection in an animal model. Ann. Surg. 231: 762-71.
26. Kabbinavar, F. F., Hambleton, J., Mass, R. D., Hurwitz, H. I., Bergsland, E. and Sarkar, S. (2005) Combined Analysis of Efficacy: The Addition of Bevacizumab to Fluorouracil/Leucovorin Improves Survival for Patients With Metastatic Colorectal Cancer. J. Clin. Oncol..
27. Kang, W. K., Park, C., Yoon, H. L., Kim, W. S., Yoon, S. S., Lee, M. H., Park, K., et al. (2001) Interleukin 12 gene therapy of cancer by peritumoral injection of transduced autologous fibroblasts: outcome of a phase I study. Hum. Gene Ther. 12: 671-84.
28. Lasagni, L., Francalanci, M., Annunziato, F., Lazzeri, E., Giannini, S., Cosmi, L., Sagrinati, C., et al. (2003) An alternatively spliced variant of CXCR3 mediates the inhibition of endothelial cell growth induced by IP-10, Mig, and I-TAC, and acts as functional receptor for platelet factor 4. J. Exp. Med. 197: 1537-49.
29. Leonard, J. P., Sherman, M. L., Fisher, G. L., Buchanan, L. J., Larsen, G., Atkins, M. B., Sosman, J. A., et al. (1997) Effects of single-dose interleukin-12 exposure on interleukin-12-associated toxicity and interferon-gamma production. Blood 90: 2541-8.
30. Liu, Y., Ehtesham, M., Samoto, K., Wheeler, C. J., Thompson, R. C., Villarreal, L. P., Black, K. L., et al. (2002) In situ adenoviral interleukin 12 gene transfer confers potent and long-lasting cytotoxic immunity in glioma. Cancer Gene Ther. 9: 9-15.
31. Lode, H. N., Dreier, T., Xiang, R., Varki, N. M., Kang, A. S. and Reisfeld, R. A. (1998) Gene therapy with a single chain interleukin 12 fusion protein induces T cell-dependent protective immunity in a syngeneic model of murine neuroblastoma. Proc. Natl. Acad. Sci. USA 95: 2475-80.
32. Masztalerz, A., Van Luyn, M., Werner, N., Molema, G., Everse, L. A. and Otter, W. D. (2004) Treatment with IL-2 and IL-12 inhibits tumour cell division in SL2 lymphoma. Anticancer Res. 24: 2633-42.
33. Mazzolini, G., Alfaro, C., Sangro, B., Feijoo, E., Ruiz, J., Benito, A., Tirapu, I., et al. (2005) Intratumoral injection of dendritic cells engineered to secrete interleukin-12 by recombinant adenovirus in patients with metastatic gastrointestinal carcinomas. J. Clin. Oncol. 23: 999-1010.
34. Mazzolini, G., Narvaiza, I., Bustos, M., Duarte, M., Tirapu, I., Bilbao, R., Qian, C., et al. (2001) Alpha(v)beta(3) integrin-mediated adenoviral transfer of interleukin-12 at the periphery of hepatic colon cancer metastases induces VCAM-1 expression and T-cell recruitment. Mol. Ther. 3: 665-72.
35. Mazzolini, G., Narvaiza, I., Perez-Diez, A., Rodriguez-Calvillo, M., Qian, C., Sangro, B., Ruiz, J., et al. (2001) Genetic heterogeneity in the toxicity to systemic adenoviral gene transfer of interleukin-12. Gene Ther. 8: 259-67.
36. Mazzolini, G., Qian, C., Narvaiza, I., Barajas, M., Borras-Cuesta, F., Xie, X., Duarte, M., et al. (2000) Adenoviral gene transfer of interleukin 12 into tumors synergizes with adoptive T cell therapy both at the induction and effector level. Hum. Gene Ther. 11: 113-25.
37. Mazzolini, G., Qian, C., Xie, X., Sun, Y., Lasarte, J. J., Drozdzik, M. and Prieto, J. (1999) Regression of colon cancer and induction of antitumor immunity by intratumoral injection of adenovirus expressing interleukin-12. Cancer Gene Ther. 6: 514-22.
38. Melero, I., Duarte, M., Ruiz, J., Sangro, B., Galofre, J., Mazzolini, G., Bustos, M., et al. (1999) intratumoral injection of bone-marrow derived dendritic cells engineered to produce interleukin-12 induces complete regression of established murine transplantable colon adenocarcinomas. Gene Ther. 6: 1779-84.
39. Nanni, P., Rossi, I., De Giovanni, C., Landuzzi, L., Nicoletti, G., Stoppacciaro, A., Parenza, M., et al. (1998) Interleukin 12 gene therapy of MHC-negative murine melanoma metastases. Cancer Res. 58: 1225-30.
40. Nasu, Y., Bangma, C. H., Hull, G. W., Lee, H. M., Hu, J., Wang, J., McCurdy, M. A., et al. (1999) Adenovirus-mediated interleukin-12 gene therapy for prostate cancer: suppression of orthotopic tumor growth and pre-established lung metastases in an orthotopic model. Gene Ther. 6: 338-49.
41. Nishioka, Y., Hirao, M., Robbins, P. D., Lotze, M. T. and Tahara, H. (1999) Induction of systemic and therapeutic antitumor immunity using intratumoral injection of dendritic cells genetically modified to express interleukin 12. Cancer Res. 59: 4035-41.
42. Palmer, K., Hitt, M., Emtage, P. C., Gyorffy, S. and Gauldie, J. (2001) Combined CXC chemokine and interleukin-12 gene transfer enhances antitumor immunity. Gene Ther. 8: 282-90.
43. Parihar, R., Nadella, P., Lewis, A., Jensen, R., De Hoff, C., Dierksheide, J. E., VanBuskirk, A. M., et al. (2004) A phase I study of interleukin 12 with trastuzumab in patients with human epidermal growth factor receptor-2-overexpressing malignancies: analysis of sustained interferon gamma production in a subset of patients. Clin. Cancer Res. 10: 5027-37.
44. Paul, D., Qazilbash, M. H., Song, K., Xu, H., Sinha, B. K., Liu, J. and Cowan, K. H. (2000) Construction of a recombinant adeno-associated virus (rAAV) vector expressing murine interleukin-12 (IL-12) Cancer Gene Ther. 7: 308-15.
45. Peñuelas, I., Mazzolini, G., Boán, J. F., Sangro, B., Martí-Climent, J., Ruiz, M., Satyamurthy, N., et al. (2005) Positron emission tomography imaging of adenoviral-mediated transgene expression in liver cancer patients. Gastroenterology (in press)
46. Peron, J. M., Couderc, B., Rochaix, P., Douin-Echinard, V., Asnacios, A., Souque, A., Voigt, J. J., et al. (2004) Treatment of murine hepatocellular carcinoma using genetically modified cells to express interleukin-12. J. Gastroenterol. Hepatol. 19: 388-96.
47. Popovic, D., El-Shami, K. M., Vadai, E., Feldman, M., Tzehoval, E. and Eisenbach, L. (1998) Antimetastatic vaccination against Lewis lung carcinoma with autologous tumor cells modified to express murine interleukin 12. Clin. Exp. Metastasis 16: 623-32.
48. Prieto, J., Qian, C., Sangro, B., Melero, I. and Mazzolini, G. (2004) Biologic therapy of liver tumors. Surg. Clin. North. Am. 84: 673-96.
49. Putzer, B. M., Stiewe, T., Rodicker, F., Schildgen, O., Ruhm, S., Dirsch, O., Fiedler, M., et al. (2001) Large nontransplanted hepatocellular carcinoma in woodchucks: treatment with adenovirus-mediated delivery of interleukin 12/B7.1 genes. J. Natl. Cancer Inst. 93: 472-9.
50. Qiao, J., Chen, S. H., Pham-Nguyen, K. B., Mandeli, J. and Woo, S. L. (1999) Construction and characterization of a recombinant adenoviral vector expressing human interleukin-12. Cancer Gene Ther. 6: 373-9.
51. Rakhit, A., Yeon, M. M., Ferrante, J., Fettner, S., Nadeau, R., Motzer, R., Bukowski, R., et al. (1999) Down-regulation of the pharmacokinetic-pharmacodynamic response to interleukin-12 during long-term administration to patients with renal cell carcinoma and evaluation of the mechanism of this "adaptive response" in mice. Clin. Pharmacol. Ther. 65: 615-29.
52. Rakhmilevich, A. L., Hooper, A. T., Hicklin, D. J. and Sondel, P. M. (2004) Treatment of experimental breast cancer using interleukin-12 gene therapy combined with anti-vascular endothelial growth factor receptor-2 antibody. Mol. Cancer Ther. 3: 969-76.
53. Ribas, A., Amarnani, S. N., Buga, G. M., Butterfield, L. H., Dissette, V. B., McBride, W. H., Glaspy, J. A., et al. (2002) Immunosuppressive effects of interleukin-12 coexpression in melanoma antigen gene-modified dendritic cell vaccines. Cancer Gene Ther. 9: 875-83.
54. Ryffel, B. (1997) Interleukin-12: role of interferon-gamma in IL-12 adverse effects. Clin. Immunol. Immunopathol. 83: 18-20.
55. Sacco, S., Heremans, H., Echtenacher, B., Buurman, W. A., Amraoui, Z., Goldman, M. and Ghezzi, P. (1997) Protective effect of a single interleukin-12 (IL-12) predose against the toxicity of subsequent chronic IL-12 in mice: role of cytokines and glucocorticoids. Blood 90: 4473-9.
56. Saika, T., Satoh, T., Kusaka, N., Ebara, S., Mouraviev, V. B., Timme, T. L. and Thompson, T. C. (2004) Route of administration influences the antitumor effects of bone marrow-derived dendritic cells engineered to produce interleukin-12 in a metastatic mouse prostate cancer model. Cancer Gene Ther. 11: 317-24.
57. Sangro, B., Gil, A., Díaz, L., Ruiz, J., Córdoba, M., Barajas, M., Bustos, M., et al. (2000) Safety Issues of Interleukin 12 Gene Therapy using Adenoviral Vectors. Mol. Ther. 1: S532.
58. Sangro, B., Mazzolini, G., Ruiz, J., Herraiz, M., Quiroga, J., Herrero, I., Benito, A., et al. (2004) Phase I trial of intratumoral injection of an adenovirus encoding interleukin-12 for advanced digestive tumors. J. Clin. Oncol. 22: 1389-97.
59. Schultz, J., Pavlovic, J., Strack, B., Nawrath, M. and Moelling, K. (1999) Long-lasting anti-metastatic efficiency of interleukin 12-encoding plasmid DNA. Hum. Gene Ther. 10: 407-17.
60. Sunamura, M., Sun, L., Lozonschi, L., Duda, D. G., Kodama, T., Matsumoto, G., Shimamura, H., et al. (2000) The antiangiogenesis effect of interleukin 12 during early growth of human pancreatic cancer in SCID mice. Pancreas 20: 227-33.
61. Sung, M. W., Chen, S. H., Thung, S. N., Zhang, D. Y., Huang, T. G., Mandeli, J. P. and Woo, S. L. (2002) Intratumoral delivery of adenovirus-mediated interleukin-12 gene in mice with metastatic cancer in the liver. Hum. Gene Ther. 13: 731-43.
62. Tahara, H., Zeh, H. J., 3rd, Storkus, W. J., Pappo, I., Watkins, S. C., Gubler, U., Wolf, S. F., et al. (1994) Fibroblasts genetically engineered to secrete interleukin 12 can suppress tumor growth and induce antitumor immunity to a murine melanoma in. vivo. Cancer Res. 54: 182-9.
63. Tirapu, I., Arina, A., Mazzolini, G., Duarte, M., Alfaro, C., Feijoo, E., Qian, C., et al. (2004) Improving efficacy of interleukin-12-transfected dendritic cells injected into murine colon cancer with anti-CD137 monoclonal antibodies and alloantigens. Int. J. Cancer 110: 51-60.
64. Wang, L., Hernandez-Alcoceba, R., Shankar, V., Zabala, M., Kochanek, S., Sangro, B., Kramer, M. G., et al. (2004) Prolonged and inducible transgene expression in the liver using gutless adenovirus: a potential therapy for liver cancer. Gastroenterology 126: 278-89.
65. Wong, R. J., Chan, M. K., Yu, Z., Ghossein, R. A., Ngai, I., Adusumilli, P. S., Stiles, B. M., et al. (2004) Angiogenesis inhibition by an oncolytic herpes virus expressing interleukin 12. Clin. Cancer Res. 10: 4509-16.
66. Wong, R. J., Chan, M. K., Yu, Z., Kim, T. H., Bhargava, A., Stiles, B. M., Horsburgh, B. C., et al. (2004) Effective intravenous therapy of murine pulmonary metastases with an oncolytic herpes virus expressing interleukin 12. Clin. Cancer Res. 10: 251-9.
67. Zabala, M., Wang, L., Hernandez-Alcoceba, R., Hillen, W., Qian, C., Prieto, J. and Kramer, M. G. (2004) Optimization of the Tet-on system to regulate interleukin 12 expression in the liver for the treatment of hepatic tumors. Cancer Res. 64: 2799-804.
68. Zhang, R. and DeGroot, L. J. (2003) Gene therapy of a rat follicular thyroid carcinoma model with adenoviral vectors transducing murine interleukin-12. Endocrinology 144: 1393-8.
69. Zheng, S., Xiao, Z. X., Pan, Y. L., Han, M. Y. and Dong, Q. (2003) Continuous release of interleukin 12 from microencapsulated engineered cells for colon cancer therapy. World J. Gastroenterol. 9: 951-5.
70. Zitvogel, L., Tahara, H., Cai, Q., Storkus, W. J., Muller, G., Wolf, S. F., Gately, M., et al. (1994) Construction and characterization of retroviral vectors expressing biologically active human interleukin-12. Hum. Gene Ther. 5: 1493-506.
71. Zou, W. (2005) Immunosuppressive networks in the tumour environment and their therapeutic relevance. Nat. Rev. Cancer 5: 263-74.